首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.
【2h】

Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.

机译:比较具有7-氮杂环丁烷环取代基的六种新的单氟喹诺酮和二氟喹诺酮3-羧酸的体外和体内活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

E-4502, E-4501, E-4500, E-4480, E-4474, and E-4441 are new monofluorinated or difluorinated quinolone agents that are chemically characterized by the presence of an azetidin ring, with different C'-3 substituents, at position 7 of the molecular structure. The MICs of the difluorinated compounds E-4501, E-4474, and E-4441 for 90% of isolates were 0.06 to 1, 0.06 to 1, and 0.12 to 1 microgram/ml, respectively, against gram-positive organisms (staphylococci, streptococci, and Enterococcus faecalis); 0.0015 to 0.12, 0.015 to 0.12, and 0.03 to 0.12 microgram/ml, respectively, against members of the family Enterobacteriaceae except Providencia spp.; and 1, 1, and 2 micrograms/ml, respectively, against Pseudomonas aeruginosa. E-4501, E-4474, and E-4441 inhibited all anaerobic bacteria at concentrations of 1, 2, and 4 micrograms/ml, respectively. Difluorinated compounds were significantly more active than the corresponding monofluorinated analogs E-4502, E-4500, and E-4480 against aerobic and facultatively anaerobic organisms, as well as against anaerobes. Considering monofluorinated and difluorinated compounds, activity in moderate ascending order was observed in quinolones containing an amine and a methyl group (E-4441 and E-4480), an amine group (E-4474 and E-4500), and a methylamine group (E-4501 and E-4502) in the C'-3 position of the azetidin ring. E-4501, E-4474, and E-4441 were more active than norfloxacin and DR-3355 [S-(-)-ofloxacin], had activities comparable to or slightly lower than that of ciprofloxacin against gram-negative bacteria, and were more active than all the reference quinolones against gram-positive organisms and anaerobes. E-4502 and E-4501, which were used to determine the effect of pH, were less active in acidic medium. In general, E-4502, E-4501, E-4500, E-4480, E-4474, and E-4441 activities were not affected or increased in medium containing serum but decreased in the presence of 10 mM Mg2+ or in human urine at pH 5.5. The protective effect of E-4501, E-4474, and E-4441 after oral administration against systemic infections with Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa in mice was greater than that of ciprofloxacin.
机译:E-4502,E-4501,E-4500,E-4480,E-4474和E-4441是新型单氟化或二氟化喹诺酮试剂,其化学特征是存在氮杂环丁烷环,具有不同的C'-3取代基,位于分子结构的7位。对于革兰氏阳性生物体(葡萄球菌,大肠杆菌),90%分离物的二氟化合物E-4501,E-4474和E-4441的MIC分别为0.06至1,0.06至1,和0.12至1微克/毫升。链球菌和粪肠球菌);除Provenncia spp。外,对肠杆菌科的成员分别为0.0015至0.12、0.015至0.12和0.03至0.12微克/毫升;和分别对铜绿假单胞菌1、1和2微克/毫升。 E-4501,E-4474和E-4441分别以1、2和4微克/毫升的浓度抑制所有厌氧菌。二氟化合物比相应的单氟类似物E-4502,E-4500和E-4480对需氧和兼性厌氧生物以及厌氧菌更具活性。考虑到单氟和二氟化合物,在含有胺和甲基(E-4441和E-4480),胺基(E-4474和E-4500)和甲胺基( E-4501和E-4502)位于氮杂环丁烷环的C'-3位置。 E-4501,E-4474和E-4441比诺氟沙星和DR-3355 [S-(-)-氧氟沙星]具有更高的活性,对革兰氏阴性细菌的活性与环丙沙星相当或略低于环丙沙星,并且比所有参比喹诺酮类对革兰氏阳性生物和厌氧菌的活性更高。用于确定pH值影响的E-4502和E-4501在酸性介质中的活性较低。通常,在含有血清的培养基中,E-4502,E-4501,E-4500,E-4480,E-4474和E-4441的活性不会受到影响或增加,但在10 mM Mg2 +存在下或在人尿中会降低在pH 5.5。口服后,E-4501,E-4474和E-4441对金黄色葡萄球菌,大肠埃希菌和铜绿假单胞菌的全身感染对小鼠的保护作用大于环丙沙星。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号